Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “mifepristone”

9 pharma patents match "mifepristone" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 9
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 9 pharmaceutical patents matching "mifepristone" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

9 results for “mifepristone” · 30,257 patents in full index Clear search

  1. US 11173165

    Optimizing mifepristone levels for Cushing's patients

    Corcept Therapeutics Incorporated · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted

  2. US 10842801

    Optimizing mifepristone absorption

    Corcept Therapeutics Incorporated · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted

  3. US 10660904

    Optimizing mifepristone levels for cushing's patients

    Corcept Therapeutics Incorporated · Granted May 26, 2020 · Expires May 21, 2040

    granted

  4. US 10500216

    Optimizing mifepristone absorption

    Corcept Therapeutics Incorporated · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  5. US 10166242

    Optimizing mifepristone levels for Cushing's patients

    Corcept Therapeutics Incorporated · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  6. US 10166243

    Optimizing mifepristone levels for cushing'S patients

    Corcept Therapeutics Incorporated · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  7. US 9943526

    Optimizing mifepristone levels for cushing's patients

    Corcept Therapeutics Incorporated · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  8. US 8921348

    Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists

    Corcept Therapeutics Incorporated · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  9. US 8598149

    Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists

    Corcept Therapeutics Incorporated · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.